US civilian smallpox preparedness and response program, 2003

Clinical Infectious Diseases

Volumn 46, Issue SUPPL. 3, 2008, Pages

  Strikas, Raymond A ^a   Neff, Linda J ^b   Rotz, Lisa ^b   Cono, Joanne ^b   Knutson, Donna ^b   Henderson, Joseph ^b   Orenstein, Walter A ^c  

^a U S DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIDOFOVIR; SMALLPOX VACCINE; VACCINIA ANTIBODY; DRYVAX VACCINE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ANGINA PECTORIS; ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DISEASE SEVERITY; DRUG CONTRAINDICATION; DRUG SAFETY; ECZEMA; ECZEMA VACCINATUM; FEMALE; FOOD AND DRUG ADMINISTRATION; HEALTH PROGRAM; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL EDUCATION; MYOCARDITIS; PATIENT CARE; PERICARDITIS; PREGNANCY; PRIORITY JOURNAL; SMALLPOX; VACCINATION; VACCINIA; BIOLOGICAL WARFARE; CIVIL DEFENSE; DISASTER PLANNING; GOVERNMENT; HEALTH CARE PERSONNEL; HEALTH SURVEY; IMMUNIZATION; MANPOWER; MASS IMMUNIZATION; METHODOLOGY; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; PUBLIC HEALTH SERVICE; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOTERRORISM; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); CIVIL DEFENSE; DISASTER PLANNING; FEMALE; HEALTH PERSONNEL; HUMANS; IMMUNIZATION, SECONDARY; MALE; MASS IMMUNIZATION; MIDDLE AGED; SENTINEL SURVEILLANCE; SMALLPOX; SMALLPOX VACCINE; UNITED STATES; UNITED STATES DEPT. OF HEALTH AND HUMAN SERVICES;

EID: 41649105729     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/524751     Document Type: Article

References (54)

1. Biological and chemical terrorism: strategic plan for preparedness and response; recommendations of the CDC Strategic Planning Workgroup. MMWR Recomm Rep 2000; 49(RR-4):1-14.
2. Henderson DA. The looming threat of bioterrorism. Science 1999; 283:1279-82.
3. CDC. Smallpox response plan and guidelines: guide B - vaccination guidelines for state and local public health agencies. Available at: http://www.bt.cdc.gov/agent/smallpox/response-plan/files/guide-b-part1of 3.doc. Accessed 23 July 2007.
4. Wharton M, Strikas R, Harpaz R, et al. Recommendations for using smallpox vaccine in a pre-event vaccination program: supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep 2003; 52(RR-7):1-16.
5. President delivers remarks on smallpox. Available at: http://www.whitehouse.gov/news/releases/2002/12/20021213-7.html. Accessed 26 July 2007.
6. Grabenstein JD, Winkenwerder Jr W. U.S. military smallpox vaccination program experience. JAMA 2003; 289:3278-82.
7. Amendment to extend for one year the January 24, 2003, declaration regarding administration of smallpox countermeasures, as amended on January 24, 2004, January 24, 2005, January 24, 2006 and January 24, 2007. Available at: http://www.hrsa.gov/smallpoxinjury/frn012907.htm. Accessed 7 August 2007.
8. CDC telebriefing transcript: HHS teleconference on smallpox policy. 14 December 2002. Available at: http://www.cdc.gov/od/oc/media/transcripts/ t021214.htm. Accessed 24 August 2007.
9. CDC. Smallpox response plan and guidelines (version 3.0). Available at: http://emergency.cdc.gov/agent/smallpox/response-plan/. Accessed 26 July 2007.
10. CDC. Smallpox pre-vaccination information packet. Available at: http://www.bt.cdc.gov/agent/smallpox/vaccination/infopacket.asp. Accessed 25 August 2007.
11. CDC. Update: adverse events following smallpox vaccination - United States, 2003. MMWR Morb Mortal Wkly Rep 2003; 52:278-82.
12. Rotz L, Dotson D, Damon I, Becher J, Advisory Committee on Immunization Practices. Vaccinia (smallpox) vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2001. MMWR Recomm Rep 2001; 50(RR-10):1-25.
13. CDC. Countermeasure and response administration. Available at: http://www.cdc.gov/phin/activities/applications-services/cra/system.html. Accessed 7 August 2007.
14. Clark PT, Levin S. The Smallpox Vaccine Injury Compensation Program. Clin Infect Dis 2008; 46(Suppl 3):S179-81 (in this supplement).
15. Muralles A, Black S, Shinefield H, et al. Active telephone surveillance to evaluate adverse events among civilian smallpox vaccine recipients. Vaccine 2006; 24:476-84.
16. Thomas TN, Reef S, Neff L, Sniadack MM, Mootrey GT. A review of the Smallpox Vaccine Adverse Events Active Surveillance system. Clin Infect Dis 2008; 46(Suppl 3):S212-20 (in this supplement).
17. Klevens M, Lawton R, Kupronis B. Rapid deployment of a surveillance system: the hospital smallpox vaccination monitoring system (HSVMS) experience [abstract 827]. In: Program and abstracts of the 41st Annual Meeting of the Infectious Diseases Society of America (San Diego, California). Alexandria, Virginia: Infectious Diseases Society of America, 2003:173.
18. Ryan MAK, Seward JF, for the Smallpox Vaccine in Pregnancy Registry Team. Pregnancy, birth, and infant health outcomes from the National Smallpox Vaccine in Pregnancy Registry, 2003-2006. Clin Infect Dis 2008; 46(Suppl 3):S221-6 (in this supplement).
19. Neff J, Modlin J, Birkhead GS, et al. Monitoring the safety of a smallpox vaccination program in the United States: report of the joint Smallpox Vaccine Safety Working Group of the Advisory Committee on Immunization Practices and the Armed Forces Epidemiological Board. Clin Infect Dis 2008; 46(Suppl 3):S258-70 (in this supplement).
20. Lane JM, Ruben FL, Neff JM, Millar JD. Complications of smallpox vaccination, 1968: results of ten statewide surveys. J Infect Dis 1970; 122:303-9.
21. Hutchins SS, Sulemana I, Heilpern KL, et al. Performance of an algorithm for assessing smallpox risk among patients with rashes that may be confused with smallpox. Clin Infect Dis 2008; 46(Suppl 3):S195-203 (in this supplement).
22. Morse SA, Kellogg RB, Perry RF, et al. Detecting biothreat agents: the Laboratory Response Network. ASM News 2003; 69:433-7. Available at: http://www.asm.org/microbe/index.asp?bid=21330. Accessed 8 January 2008.
23. CDC. Facts about the Laboratory Response Network. Available at: http://www.bt.cdc.gov/lrn/factsheet.asp. Accessed 12 July 2007.
24. Frey SE, Couch RB, Tacket CO, et al. Clinical responses to undiluted and diluted smallpox vaccine. N Engl J Med 2002; 346:1265-74.
25. FDA approves second-generation smallpox vaccine. Available at: http://www.fda.gov/bbs/topics/NEWS/2007/NEW01693.html. Accessed 4 September 2007.
26. CDC. Guidance for post-event smallpox planning. 29 October 2002. Available at: http://emergency.cdc.gov/agent/smallpox/prep/postevent-guidance. asp. Accessed 24 January 2008.
27. Institute of Medicine. The smallpox vaccination program: public health in an age of terrorism. Washington, D.C.: National Academies Press, 2005.
28. Wortley P, Schwartz B, Levy P, Quick L, Evans B, Burke B. Healthcare workers who elected not to receive smallpox vaccination. Am J Prev Med 2006; 30:258-65.
29. Lindley M, Wortley P, Winston C, Schwartz B. Programmatic factors related to smallpox vaccine uptake by healthcare workers and others. Infect Control Hosp Epidemiol 2006; 27:1242-5.
30. Wortley P, Levy P, Quick L, et al. Predictors of smallpox vaccination among healthcare workers and other first responders. Am J Prev Med 2007; 32:538-41.
31. Sniadack MM, Neff LJ, Swerdlow DL, Schieber RA, McCauley MM, Mootrey GT. Follow-up of cardiovascular adverse events after smallpox vaccination among civilians in the United States, 2003. Clin Infect Dis 2008; 46(Suppl 3):S251-7 (in this supplement).
32. Continuation guidance for cooperative agreement on public health preparedness and response for bioterrorism - budget year five program announcement. 14 June 2004. Available at: http://www.bt.cdc.gov/planning/ continuationguidance/pdf/guidance_intro.pdf. Accessed 8 August 2007.
33. Continuation guidance for cooperative agreement on public health preparedness and response for bioterrorism - budget year six program announcement. 2005. Available at: http://www.bt.cdc.gov/planning/ guidance05/pdf/annoucement.pdf. Accessed 8 August 2007.
34. Cono J, Casey C, Bell D, Centers for Disease Control and Prevention. Smallpox vaccination and adverse reactions. MMWR Recomm Rep 2003; 52(RR-4):1-28.
35. Casey C, Velozzi C, Mootrey G, et al. Surveillance guidelines for smallpox vaccine (vaccinia) adverse reactions. MMWR Recomm Rep 2006; 55(RR-1):1-16.
36. Casey C, Iskander J, Roper M, et al. Adverse events associated with smallpox vaccination in the United States, January-October, 2003. JAMA 2005; 294:2734-43.
37. CDC. Update: adverse events following civilian smallpox vaccination - United States, 2003. MMWR Morb Mortal Wkly Rep 2004; 53:106-7.
38. Wilcox AJ, Weinberg CR, O'Connor JF, et al. Incidence of early loss of pregnancy. N Engl J Med 1988; 319:189-94.
39. Ventura SJ, Hamilton BE, Sutton PD. Revised birth and fertility rates for the United States, 2000 and 2001. Natl Vital Stat Rep 2003; 51:1-18.
40. Ananth C, Ananth CV, Liu S, Kinzler WL, Kramer MS. Stillbirths in the United States, 1981-2000: an age, period, and cohort analysis. Am J Public Health 2005; 95:2213-7.
41. Martin JA, Hamilton BE, Sutton PD, Ventura SJ, Menacker F, Munson ML. Births: final data for 2003. Natl Vital Stat Rep 2005; 54(2):1-116.
42. National Birth Defects Prevention Network. Birth defects surveillance data from selected states, 1998-2002. Birth Defects Res A Clin Mol Teratol 2005; 73:758-853.
43. Morgan J, Roper MH, Sperling L, et al. Myocarditis, pericarditis, and dilated cardiomyopathy after smallpox vaccination among civilians in the United States, January-October 2003. Clin Infect Dis 2008; 46(Suppl 3):S242-50 (in this supplement).
44. Swerdlow DL, Roper MH, Morgan J, et al. Ischemic cardiac events during the US Department of Health and Human Services smallpox vaccination program, 2003. Clin Infect Dis 2008; 46(Suppl 3):S234-41 (in this supplement).
45. CDC. Smallpox vaccine adverse events among civilians - United States, February 25-March 3, 2003. MMWR Morb Mortal Wkly Rep 2003; 52:180-1, 191.
46. US Department of Defense. DoD smallpox vaccination program: safety summary, 17 May 2007. Available at: http://www.smallpox.mil/event/SPSafetySum. asp. Accessed 21 July 2007.
47. CDC. Household transmission of vaccinia virus from contact with a military smallpox vaccinee - Illinois and Indiana, 2007. MMWR Morb Mortal Wkly Rep 2007; 56:478-81.
48. Hutchins S, Marin M, Seward J, Damon I, CDC Rash Illness Team. Smallpox disease surveillance - United States, 2002-2003 [abstract 73883]. In: Program and abstracts of the 131st Annual Meeting of the American Public Health Association (San Francisco). Washington, DC: American Public Health Association, 2003. Available at: http://apha.confex.com/apha/131am/techprogram/ paper_73883.htm. Accessed 23 July 2007.
49. Current status of state pre-event smallpox vaccination programs - October 15, 2003. Arlington, Virginia: Association of State and Territorial Health Officials, 2003.
50. Federal Department [of Health and Human Services] Point of Contact Letter regarding state pandemic plans. 26 January 2007. Available at: http://www.pandemicflu.gov/plan/states/stateoperatingplanattach.html. Accessed 25 August 2007.
51. HHS pandemic influenza plan part 2: public health guidance on pandemic influenza for state and local partners. Available at: http://www.hhs.gov/ pandemicflu/plan/part2.html. Accessed 27 August 2007.
52. CDC. Smallpox vaccination status and procedures - guidelines for grantees using licensed undiluted Wyeth Dryvax vaccine. Available at: http://www.bt.cdc.gov/agent/smallpox/vaccination/statusprocedure.asp. Accessed 26 July 2007.
53. CDC. Multistate outbreak of monkeypox - Illinois, Indiana, Wisconsin, 2003. MMWR Morb Mortal Wkly Rep 2003; 52:537-40.
54. National strategy for pandemic influenza: implementation plan. Chapter 6: protecting human health. Available at: http://www.whitehouse.gov/homeland/ pandemic-influenza-implementation.html. Accessed 8 August 2007.